Listed

Genprex, Inc.: Form 10-Q for the period ended Sep 30, 2025

Filed with the SEC on Nov 14, 2025 and accepted by EDGAR at Nov 14, 2025, 16:11 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2025-07-01 to 2025-09-30$2.2mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2025-01-01 to 2025-09-30$7.2mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2025-07-01 to 2025-09-30−$3.3mus-gaap:OperatingIncomeLoss
Operating income9 months2025-01-01 to 2025-09-30−$12.0mus-gaap:OperatingIncomeLoss
Net income3 months2025-07-01 to 2025-09-30−$3.8mus-gaap:NetIncomeLoss
Net income9 months2025-01-01 to 2025-09-30−$12.4mus-gaap:NetIncomeLoss
Basic EPS3 months2025-07-01 to 2025-09-30−$5.00us-gaap:EarningsPerShareBasic
Basic EPS9 months2025-01-01 to 2025-09-30−$23.00us-gaap:EarningsPerShareBasic
Operating cash flow9 months2025-01-01 to 2025-09-30−$11.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2025-09-30$1.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2025-09-30$1.7mus-gaap:AssetsCurrent
Total assetsAt period end2025-09-30$3.6mus-gaap:Assets
Current liabilitiesAt period end2025-09-30$2.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2025-09-30$2.8mus-gaap:Liabilities
Shareholders' equityAt period end2025-09-30$767.8kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-25-035191. Last ingested by Listed: Oct 28, 2026, 07:02 ET. Listed shows no prices and gives no investment advice.